Sagamore Spirit is nearing the start of production of large quantities of antimicrobial hand sanitizer to help meet the urgent needs of healthcare workers and first responders on the front lines of the COVID-19 pandemic. The Maryland Rye distiller has procured materials sufficient to manufacture an initial 54,000 liters of hand sanitizer that will first be made available to Maryland health providers including Johns Hopkins, which has been advising the company on manufacturing the vital sanitizer to WHO and FDA standards for safety and efficacy.
If certain supply chain and regulatory challenges can be solved, the company is prepared to produce up to 100,000 liters of sanitizer per month. First, Sagamore Spirit needs to procure packaging that became in short supply once COVID-19’s potential domestic impact was realized. Next, Congress needs to temporarily waive an arcane statute during this healthcare crisis that requires the use of isopropyl alcohol for denaturing, which the WHO deems unnecessary to manufacture safe and effective hand sanitizer. Sagamore Spirit has procured enough isopropyl alcohol to produce the initial 54,000-liter run, but since it is in short supply, the distiller’s ability to expand to the potential 100,000-liter monthly production level entirely depends on Congress’s willingness to waive the denaturing requirement.
Sagamore Spirit has been closely monitoring developments in non-traditional hand sanitizer production, including efforts made by other distillers. The company immediately began studying what compliant manufacturing at a meaningful scale would entail before starting production, with a goal to sustainably produce and supply hand sanitizer to Maryland’s healthcare workers and first responders. Sagamore’s manufacturing capacity could potentially supply needs beyond Maryland, as well.




